Prochlorperazine Maleate NDC 68462-889

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-889Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0889Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68462-889-01	68462088901	100 TABLET in 1 BOTTLE (68462-889-01)Marketed from Mar 17, 2023
68462-889-10	68462088910	1000 TABLET in 1 BOTTLE (68462-889-10)Marketed from Mar 17, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Prochlorperazine Maleate
Generic name (nonproprietary): prochlorperazine maleate
Active ingredients: Prochlorperazine maleate — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: GLENMARK PHARMACEUTICALS INC., USA
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216595
Marketing start: Mar 17, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Phenothiazines (Chemical structure)
Identifiers: Product ID 68462-889_87ee1668-fd00-4e54-8c72-14ca91b94e0eSPL ID 87ee1668-fd00-4e54-8c72-14ca91b94e0eSPL set ID 9c806152-70d0-43eb-b183-b51b12b82b31RxCUI 198365, 312635UNII I1T8O1JTL6UPC 0368462947012
Pharmacologic class: Phenothiazine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462088901 followed by a unit qualifier and the quantity

Package 68462-0889-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 27, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE For control of severe nausea and vomiting. For the treatment of schizophrenia. Prochlorperazine is effective for the short-term treatment of generalized non-psychotic anxiety. However, prochlorperazine is not the first drug to be used in therapy for most patients with non-psychotic anxiety, because certain risks associated with its use are not shared by common alternative treatments (e.g., benzodiazepines). When used in the treatment of non-psychotic anxiety, prochlorperazine should not be administered at doses of more than 20 mg per day or for longer than 12 weeks, because the use of prochlorperazine at higher doses or for longer intervals may cause persistent tardive …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216595

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216595
Product	Strength	Form · route	Labeler	Product NDC
Prochlorperazine Maleate	Prochlorperazine maleate 10 mg/1	TabletOral	GLENMARK PHARMACEUTICALS INC., USA	68462-947